3rd IVF Worldwide Online Congress On-Demand Recordings

Click on the session title that has an icon next to it to view the on-demand recording

To display the video full-screen click on the icon

Session 1: Opening / New innovation in Reproductive Medicine
Supported by Abbott
Innovative methods and cutting edge technologies in the laboratory that will impact the patient journey
Denny Sakkas, USA
Home fertility care
John Zhang, USA
Embryo culture: Past present and future
David Gardner, Australia
Session 2: New innovation in Reproductive Medicine
Making oocytes from skin biopsy in humans: The eight genes needed to go directly from IPS cell to oocyte, and how we can make fetal granulose cells similarly from just a few growth factors.
Sherman Silber, USA
Detection of balanced rearrangements in embryos – comprehensive PGT-SR
Svetlana Madjunkova, Canada
Session 3: The future is here: Starting the journey with AI based embryo evaluation
Supported by an unrestricted educational grant by Vitrolife
Standardizing embryo evaluation workflow using artificial intelligence
Simon Cooke, Scientific Director of IVF Australia
iDAScore behind the scenes : Towards fully automatic embryo evaluation
Jens Rimestad, Deep Learning specialist, Vitrolife
Experiences evaluating Vitrolife AI solutions for embryo evaluation
Tony Price, Embryology Manager at Wessex Fertility Clinic, UK
Session 4: Progesterone in ART
The pharmacodynamics and safety of progesterone in ART, what clinicians should know
Paul Piette, Belgium
Progesterone S.C. for luteal phase support in IVF treatment – an excellent opportunity
Dominique de Ziegler, France
The role of progestin in the luteal support treatment
George Griesinger, Germany
Session 5: The oocyte and the mitochondria: laboratory and clinical aspects
Moderator: Gerald Schatten, USA
Introduction: Is there paternal mtDNA leakage during Reproduction and maternal mtDNA reversal after Nuclear and/or Spindle Transfer?
Gerald Schatten, USA
The oocyte and the mitochondria – clinical perspective
Gustavo Nardini Cecchino, Brazil
Clinical aspects of Nuclear Transfers
Valery Zukin, Ukraine
Heteroplasmy level after Nuclear Transfers – from embryo to the newborn
John Zhang, USA
Embryologic aspects of Nuclear Transfers
Pavlo Mazur, Ukraine
Session 6: State of the ART 2021 (Organized by the Editors of RBMOnline)
Moderator: Bart Fauser, The Netherlands
Bart Fauser, The Netherlands
Richard Anderson, UK
Endocrine treatments of endometriosis and adenomyosis
Felice Petraglia, Italy
Infertility treatment in PCOS
Bart Fauser, The Netherlands
Bart Fauser, The Netherlands
Session 7: AI in reproductive medicine, what should we need to know about?
What you need to know about “Integrated Practice” in your IVF Unit in order to coordinate hundreds of data points to improve your IVF success rate
Markus Kupka, Germany
AI and machine learning in ART: The process and how it will enhance clinical decision making for doctors
Dean Morbeck, New Zealand
Session 8: The Growing Role of Ultrasound in Modern Reproductive Medicine. A GE Symposium
How to Incorporate 3D Into IVF and Why it Matters
Nick Raine-Fenning, UK
The ART of Reproductive Medicine: New Technology and Automation for the Reproductive Endocrinologist
Angela Palumbo, Spain
Session 9: Fertility preservation for social reasons
Supported by an unrestricted educational grant by Merck Israel
Controlled ovarian stimulation for social oocyte freezing
Ariel Weissman, Israel
Our experience with oocytes preservation for social reasons
Ana Cobo, Spain
Why are frozen oocytes still frozen? A five year follow up of women after social egg freezing
Avi Tsafrir, Israel
Session 10: Special lecture: Hysteroscopy prior or after IVF
Moderator: Moti Goldenberg
Supported by an unrestricted educational grant by Karl Storz
Hysteroscopy prior or after IVF
Rudi Campo, Belgium
Session 11: Fertility preservation in cancer patients
Supported by an unrestricted educational grant by Ferring Pharmaceuticals
The European guideline for Fertility Preservation
Michael Grynberg, France
DuoStim – a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes
Alberto Vaiarelli, Italy
Our latest techniques and results of ovarian tissue cryopreservation
Marie-Madeleine Dolmans, Belgium
Session 12: Ovarian response
The role of AMH in reproductive medicine: A critical review
Human Fatemi, UAE
The effectiveness of “rebounding” if patients do not respond at all to ovarian stimulation
Norbert Gleicher, USA
LH for ovulation induction
Robert Fischer, Germany
Session 13: Special lecture: The place of the Surgery of the Uterine Cavity in the IVF outcome improvement
The place of the Surgery of the Uterine Cavity in the IVF outcome improvement
Sergio Haimovich, Israel
Session 14: Closing / Key lecture
A case study: Unexplained implantation failure: PGT-a, ERA, Immuno-Modulation, and the microbiome
Milton Leong, HK